Literature DB >> 24915436

Altered neurochemical levels in the rat brain following chronic nicotine treatment.

Sara Falasca1, Vaclav Ranc1, Filomena Petruzziello1, Abbas Khani1, Robert Kretz1, Xiaozhe Zhang2, Gregor Rainer3.   

Abstract

Converging evidence shows that neurochemical systems are crucial mediators of nicotine dependence. Our present study evaluates the effect of 3-month chronic nicotine treatment on the levels of multiple quaternary ammonium compounds as well as glutamate and gamma aminobutyric acid in the rat prefrontal cortex, dorsal striatum and hypothalamus. We observed a marked decrease of acetylcholine levels in the dorsal striatum (22.88%, p<0.01), reflecting the impact of chronic nicotine in local interneuron circuits. We found decreases of carnitine in the dorsal striatum and prefrontal cortex (19.44%, p<0.01; 13.58%, p<0.01, respectively), but robust enhancements of carnitine in the hypothalamus (26.59%, p<0.01), which may reflect the alterations in food and water intake during chronic nicotine treatment. Finally, we identified an increase of prefrontal cortex glutamate levels (8.05%, p<0.05), supporting previous studies suggesting enhanced prefrontal activity during chronic drug use. Our study shows that quaternary ammonium compounds are regulated in a highly brain region specific manner during chronic nicotine treatment, and provides novel insights into neurochemical regulation during nicotine use.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Chronic nicotine; Dorsal striatum; Hypothalamus; Neurochemicals; Prefrontal cortex

Mesh:

Substances:

Year:  2014        PMID: 24915436     DOI: 10.1016/j.jchemneu.2014.05.002

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  7 in total

1.  A heuristic model for working memory deficit in schizophrenia.

Authors:  Zhen Qi; Gina P Yu; Felix Tretter; Oliver Pogarell; Anthony A Grace; Eberhard O Voit
Journal:  Biochim Biophys Acta       Date:  2016-05-10

2.  Modulation of social deficits and repetitive behaviors in a mouse model of autism: the role of the nicotinic cholinergic system.

Authors:  Li Wang; Luis E F Almeida; Nicholas A Spornick; Nicholas Kenyon; Sayuri Kamimura; Alfia Khaibullina; Mehdi Nouraie; Zenaide M N Quezado
Journal:  Psychopharmacology (Berl)       Date:  2015-09-04       Impact factor: 4.530

Review 3.  Targeting glutamate homeostasis for potential treatment of nicotine dependence.

Authors:  Fawaz Alasmari; Salim S Al-Rejaie; Shakir D AlSharari; Youssef Sari
Journal:  Brain Res Bull       Date:  2015-11-14       Impact factor: 4.077

4.  Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal.

Authors:  Xiomara A Perez; Taline V Khroyan; J Michael McIntosh; Maryka Quik
Journal:  Pharmacol Res Perspect       Date:  2014-12-16

5.  Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.

Authors:  Agnieszka Wąsik; Irena Romańska; Jerzy Michaluk; Agnieszka Zelek-Molik; Irena Nalepa; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2015-08-25       Impact factor: 3.911

6.  Temporal Rewiring of Striatal Circuits Initiated by Nicotine.

Authors:  Louise Adermark; Julia Morud; Amir Lotfi; Klara Danielsson; Lisa Ulenius; Bo Söderpalm; Mia Ericson
Journal:  Neuropsychopharmacology       Date:  2016-07-08       Impact factor: 7.853

7.  Repeated Administration of Cigarette Smoke Condensate Increases Glutamate Levels and Behavioral Sensitization.

Authors:  In Soo Ryu; Jieun Kim; Su Yeon Seo; Ju Hwan Yang; Jeong Hwan Oh; Dong Kun Lee; Hyun-Wook Cho; Kyuhong Lee; Seong Shoon Yoon; Joung-Wook Seo; Insop Shim; Eun Sang Choe
Journal:  Front Behav Neurosci       Date:  2018-03-16       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.